In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Rise Of Japanese Pharma Dealmakers

Executive Summary

Japanese pharmas are now serious contenders for partnerships outside their home country, increasing their spending on both alliances and acquisitions in recent years. The increased desire to partner with Western biotechs is good news for smaller industry players as the recent spate of mega-mergers has resulted in a smaller pool of potential acquirers for their assets.IN VIVO presents an analysis of recent trends in biopharmaceutical dealmaking between Japan and the West.
Advertisement

Related Content

Sanofi Pursues Genzyme, But For How Long?
Astellas Wins OSI But Victory Comes At A Price
AMAG Pharmaceuticals: Enough Irons In The Fire?
Why Doesn't Pharma Get Smaller?
Why Doesn't Pharma Get Smaller?
Takeda's Global Ambition
Takeda's Global Ambition
Trends in Japanese Alliances
Merck/Banyu: A Harbinger of More Western-Japanese Deals?
Japan: The Final Frontier

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003500

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel